GPT Healthcare Ltd

Q3 FY26Healthcare Services

GPT Healthcare Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹151

Market cap₹1.3K Cr

P/E27.1

Updated23 Aug 2026

Read4 min read

The short version

Company expects sustained double-digit growth in most hospitals, including Howrah, Agartala, and Salt Lake. Management expects EBITDA breakeven in Raipur Hospital within next 6 months, with full-year FY '27 nearly EBITDA positive.

From GPT Healthcare Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Company expects sustained double-digit growth in most hospitals, including Howrah, Agartala, and Salt Lake.
Quarter-on-quarter, existing mature hospitals have shown about 10-11% sales growth; Raipur hospital has shown 7.5% growth.
Strategy to increase occupancy rates to around 70% to 75% in mature hospitals within 1 to 1.5 years supports volume growth.
Expansion plans include a new 150-bed Jamshedpur hospital commissioning by Q4 FY '27 and pursuing further brownfield/greenfield opportunities, particularly in Eastern India.
Focus on adding high ARPOB (Average Revenue Per Occupied Bed) departments and advanced procedures (robotic surgeries, oncology, cardiology) to improve case mix and revenue per bed.
With occupancy improvement, specialized procedures, and demographic demand, the company anticipates continued revenue growth linked to higher throughput and better case mix.

Profitability & Margins

Management expects EBITDA breakeven in Raipur Hospital within next 6 months, with full-year FY '27 nearly EBITDA positive.
Jamshedpur hospital commissioning expected by Q4 FY '27, with anticipated INR 3-4 crores loss in the startup phase.
Mature hospitals like Dum Dum, Salt Lake, Agartala, and Howrah are showing double-digit revenue growth, expected to continue.
Occupancy rates targeted to reach around 70% in mature hospitals within 1 to 1.5 years, driving profitability.
ARPOB (Average Revenue Per Occupied Bed) expected to grow with inflation and improved clinical offerings.
Overall, company projects a stable margin with EBITDA of INR 65.1 crores for 9 months FY '26 and aims to build on cost discipline for future profit growth.
Expansion to 1,000 beds by 2027 via organic and inorganic growth to support scaled revenue and earnings growth.
Management optimistic about consistent double-digit growth in the medium term with improving margins.

See what GPT Healthcare Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Jamshedpur Hospital:
- Upcoming 150-bed facility, project work progressing as per schedule.
- Capex (~INR75 crores) not yet spent; will commence post developer scope of work.
- Expected commissioning by Q4 FY '27.
- Expected EBITDA losses of INR3-4 crores during commissioning phase.
Expansion towards 1,000 beds by 2027:
- Apart from Jamshedpur, actively evaluating inorganic (brownfield/greenfield) and organic opportunities in Eastern India, including Tier 2 and Tier 3 cities like Bihar, UP, and Orissa.
Focus on technology-led care delivery:
- Investment in robotic surgeries, advanced diagnostics, specialized tertiary procedures ongoing.
Raipur Hospital:
- Recently commissioned; ramping up clinical capabilities and operational capacity.
- Achieving EBITDA breakeven expected within next 6-8 months.

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹981 Cr

Rev 1Mar 1

2CHANDAN₹518 Cr

Rev 1Mar 3

3₹66.5K Cr

Rev 2Mar 1

4₹654 Cr

Rev 2Mar 2

5₹1.3L Cr

Rev 2Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The transcript does not explicitly mention any current or planned fundraising through debt or equity. However, relevant points include: - The company is investing in expanding capacity, including commissioning the Jamshedpur hospital (150 beds), with capex yet to be spent. - Management is actively pursuing and evaluating expansion opportunities, both organic and inorganic, especially in eastern India. - No direct references to raising capital via debt or equity were made during the Q&A or management commentary. - The financial focus includes disciplined cost management, improving margins, and achieving EBITDA breakeven for new hospitals (Raipur and upcoming Jamshedpur). In summary, there is no explicit mention of ongoing or planned debt/equity fundraising in this call transcript.

See what GPT Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention any details regarding the current or expected order book or pending orders for GPT Healthcare Limited. The discussion primarily focuses on: - Hospital occupancy rates and growth targets. - Expansion plans including upcoming hospitals like Jamshedpur (150 beds) and potential inorganic/organic growth opportunities in Eastern India. - Financial performance and EBITDA losses along with breakeven timelines. - Focus on departments, clinical specialties, and technology investments. - No direct references to order book or pending orders were provided in the call. If you need further details or specifics, please provide additional documents or sections to review.

GPT Healthcare Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹126 Cr, net profit ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What GPT Healthcare Ltd's management said in earlier quarters

Others in Healthcare Services this season

Vijaya Diagnostic Centre Ltd (Q3 FY26)
FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnost.'s Q3 FY26 earnings call — and…
Aster DM Quality Care Ltd (Q3 FY26)
Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…
Chandan Healthcare Ltd (Q3 FY26)
The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…
Rainbow Childrens Medicare Ltd (Q3 FY26)
Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare Institute Ltd vs Manipal Health Enterprises Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were GPT Healthcare Ltd Q3 FY26 results?

What is GPT Healthcare Ltd share price analysis?

GPT Healthcare Ltd currently shows a neutral. The stock trades at a P/E of 27.1 with a market cap of ₹1,281 Cr. Investors should review the full earnings analysis for detailed insights.

Is GPT Healthcare Ltd planning capital expenditure?

Jamshedpur Hospital: - Upcoming 150-bed facility, project work progressing as per schedule.

Keep GPT Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.